Andere talen Acarix AB Deutsche Boerse AG

Aandelen

7AC

SE0009268717

Beurs gesloten - Deutsche Boerse AG Andere beurzen 21:50:09 23-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,0247 ^EUR	-5,36%		+39,55%	+62,50%

14/05	Transcript : Acarix AB, Q1 2024 Earnings Call, May 14, 2024
14/05	Acarix AB (publ) keurt bestuursverkiezingen goed	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Acarix CPT III Code Removed from United Healthcare Medicare Advantage Noncovered List	20/05
Acarix Q1 2024 - Soft sales but strong outlook	15/05
Announcement from the annual general meeting in Acarix AB	14/05
Acarix AB Approves Board Elections	14/05
Acarix AB (publ) publishes Interim Report, January – March 2024	14/05
Acarix AB Reports Earnings Results for the First Quarter Ended March 31, 2024	14/05
Acarix secures a multi-unit order from major cardiology practice with several offices in Florida	13/05
Invitation to presentation of Acarix´s first quarter report	10/05
CADScor System is now being utilized by Leading Cardiology Practice in the New York Capital Region	06/05
Proposal by the nomination committee prior to the 2024 annual general meeting of Acarix AB (publ)	03/05
Acarix receives order from the first freestanding Emergency Room in the US	29/04
Acarix Receives Order from the First Freestanding Emergency Room in the Us	29/04
Acarix AB’s Annual Report 2023	23/04
NOTICE OF ANNUAL GENERAL MEETING IN ACARIX AB	11/04
Acarix announces the initiation of the first US-based clinical workflow evaluation study	11/04
Acarix AB Announces Initiation of the First Us-Based Clinical Workflow Evaluation Study	11/04
Acarix adopts new growth-focused business model and provides outlook update as part of our ongoing strategic review	11/04
New Health Economic Analysis Presented at ACC Highlights The Acarix CADScor System’s Cost-Effectiveness	08/04
Acarix Announces the Results from 2024 American College of Cardiology Poster Presentation to Assess the Cost-Utility of the Cadscor System	08/04
Acarix has submitted application for cross-trading at OTCQB in the US	05/04

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Acarix AB Deutsche Boerse AG

Aandelen

7AC

SE0009268717

Andere talen

Filters